Mitogen-activated protein kinase kinase negatively modulates ciliary neurotrophic factor-activated choline acetyltransferase gene expression

Eur J Biochem. 2002 Feb;269(3):850-8. doi: 10.1046/j.0014-2956.2001.02717.x.

Abstract

The expression of the choline acetyltransferase (ChAT) enzyme that synthesizes the neurotransmitter acetylcholine (ACh) is upregulated by ciliary neurotrophic factor (CNTF). We studied the involvement of the mitogen-activated protein kinase (MAPK) pathway in regulating ChAT expression in a murine septal cell line. Surprisingly, we found that PD98059 and U0126, two structurally distinct inhibitors of MAPK kinase (MEK1), increased both basal and CNTF-induced ACh production. Transient transfections with ChAT promoter-luciferase reporter construct demonstrated synergy between PD98059 and CNTF at the transcriptional level. Moreover, in cotransfection studies, overexpression of constitutively activated MEK1 completely abrogated the CNTF-mediated induction of the reporter. Blocking MEK1 did not significantly alter CNTF-induced Tyr705 phosphorylation of the principal mediator of the CNTF pathway, the transcription factor Stat3. However, PD98059 inhibited Ser727 phosphorylation of Stat3, demonstrating that the latter is MEK1-dependent. Taken together, these results indicate that activation of the MEK1/MAPK pathway inhibits the CNTF-mediated stimulation of ChAT expression, possibly as a part of a feedback mechanism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Butadienes / pharmacology
  • Cell Line
  • Choline O-Acetyltransferase / drug effects
  • Choline O-Acetyltransferase / genetics*
  • Choline O-Acetyltransferase / metabolism
  • Ciliary Neurotrophic Factor / metabolism*
  • Ciliary Neurotrophic Factor / pharmacology
  • DNA-Binding Proteins / metabolism
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / pharmacology
  • Gene Expression Regulation, Enzymologic
  • Janus Kinase 1
  • MAP Kinase Kinase 1
  • Mice
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase Kinases / metabolism*
  • Mitogen-Activated Protein Kinases / metabolism
  • Nitriles / pharmacology
  • Phosphorylation
  • Promoter Regions, Genetic
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / drug effects
  • Protein-Tyrosine Kinases / metabolism
  • STAT3 Transcription Factor
  • Trans-Activators / metabolism
  • Tyrphostins / pharmacology

Substances

  • Butadienes
  • Ciliary Neurotrophic Factor
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Flavonoids
  • Nitriles
  • STAT3 Transcription Factor
  • Stat3 protein, mouse
  • Trans-Activators
  • Tyrphostins
  • U 0126
  • alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
  • Choline O-Acetyltransferase
  • Protein-Tyrosine Kinases
  • Jak1 protein, mouse
  • Janus Kinase 1
  • Protein Serine-Threonine Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 1
  • Map2k1 protein, mouse
  • Mitogen-Activated Protein Kinase Kinases
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one